|
Neurosystemic Medicine | Epigenetic
Therapeutics
Over the
past several decades, there has been an enormous effort with improved
diagnostics to identify specific genetic changes which may lead to
psychiatric, neurodegenerative, malignant, metabolic, and autoimmune
diseases.
These global efforts within medical, pharmaceutical and biotechnology
venues have met with only moderate success. IntraTherapies clinical
initiatives are focused on new avenues of research which represent a bold
and expanded view of the molecular cause of disease, and have resulted in
the first available platform of personalized, physician managed healthcare
programs and treatments comprised of preventive and interventional
therapeutics which address the broad spectrum of disease categories
affecting long term human health and quality of life. |
